[CLDX] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
06-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -20.85%
YoY- 26.76%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 3,786 668 236 2,728 887 546 715 202.26%
PBT -22,839 -14,224 -11,259 -12,625 -10,447 -11,413 -11,779 55.18%
Tax -939 1,088 -228 -16 -4,448 -5,090 -2,990 -53.63%
NP -21,900 -14,224 -11,031 -12,625 -10,447 -11,413 -11,779 50.91%
Tax Rate - - - - - - - -
Total Cost 25,686 14,892 11,267 15,353 11,334 11,959 12,494 61.32%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin -578.45 -2,129.34 -4,674.15 -462.79 -1,177.79 -2,090.29 -1,647.41 -50.07%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -0.55 -0.36 -0.50 -0.73 -0.64 -0.75 -0.84 -24.50%
EPS Diluted -0.55 -0.36 -0.50 -0.73 -0.64 -0.75 -0.84 -24.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.